Skip to main content
SleepCited
Figure 4
Figure 4.

Valeric acid inhibits the 3D formation of MCF-7 and MDA-MB-231 cells. (A) illustrated the dynamic changes of 3D formation for MDA-MB-231 cells. (B) showed the dynamic changes of 3D formation for MCF-7 cells. Their relative cross-section area formation efficiencies were shown in (C,D). Significant reduction of cross-section area of MDA-MB-231 cells (C) and MCF-7 cells (D) in VA treated groups were observed.

Description

Epigenetic modification profiles, including histone acetylation changes, in breast cancer cells exposed to valeric acid are compared to untreated controls.

Cite This Figure

![Figure 4: Epigenetic modification profiles, including histone acetylation changes, in breast cancer cells exposed to valeric acid are compared to untreated controls.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844014/bin/41598_2021_81620_Fig4_HTML.jpg)

> Source: Fengqin Shi et al. "Valerian and valeric acid inhibit growth of breast cancer cells possibly by medi." *Scientific reports*, 2021. PMID: [33510252](https://pubmed.ncbi.nlm.nih.gov/33510252/)
<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844014/bin/41598_2021_81620_Fig4_HTML.jpg" alt="Epigenetic modification profiles, including histone acetylation changes, in breast cancer cells exposed to valeric acid are compared to untreated controls." />
  <figcaption>Figure 4. Epigenetic modification profiles, including histone acetylation changes, in breast cancer cells exposed to valeric acid are compared to untreated controls.<br>  Source: Fengqin Shi et al. "Valerian and valeric acid inhibit growth of breast cancer cells possibly by medi." <em>Scientific reports</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33510252/">33510252</a></figcaption>
</figure>